Lilly Reports Positive Phase 3 EMBER-3 Study Data In Advanced Breast Cancer
In the EMBER-3 study, estrogen receptor positive (ER+), human epidermal growth factor receptor 2 negative (HER2-) advanced breast cancer patients were randomized to receive imlunestrant alone, ...
Eli Lilly announces results from EMBER-3 study of imlunestrant
Eli Lilly (LLY) announced results from the Phase 3 EMBER-3 study of imlunestrant, an investigational, oral selective estrogen receptor ...
Indiatimes23h
Amber Enterprises India Share Price
Amber Enterprises India Ltd., incorporated in the year 1990, is a Mid Cap company (having a market cap of Rs 19,604.03 Crore) operating in Consumer Durables sector. Amber Enterprises India Ltd. key ...